Ferritin subunits in CSF are decreased in restless legs syndrome

scientific article published in February 2006

Ferritin subunits in CSF are decreased in restless legs syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.LAB.2005.06.011
P698PubMed publication ID16459164

P50authorRichard P AllenQ59195273
Christopher J EarleyQ115870570
P2093author name stringJames R Connor
John L Beard
Stacey L Clardy
P2860cites workCerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesisQ48317066
P433issue2
P304page(s)67-73
P577publication date2006-02-01
P1433published inTranslational ResearchQ15761127
P1476titleFerritin subunits in CSF are decreased in restless legs syndrome
P478volume147

Reverse relations

cites work (P2860)
Q37023585A delicate balance: Iron metabolism and diseases of the brain.
Q37258755A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD.
Q36607081A new look at an under-diagnosed poorly treated condition: restless legs syndrome.
Q37836552A possible role for secreted ferritin in tissue iron distribution
Q33486406Biophysical mechanisms of phase contrast in gradient echo MRI.
Q57065781Botulinum Toxin in Restless Legs Syndrome-A Randomized Double-Blind Placebo-Controlled Crossover Study
Q30837083CSF proteomic analysis reveals persistent iron deficiency-induced alterations in non-human primate infants
Q33587212Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults
Q33847248Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders
Q37086225Diurnal cycle influences peripheral and brain iron levels in mice
Q51930607Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis.
Q38039480European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society
Q33563777Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Q35880254High-field MRI of brain cortical substructure based on signal phase
Q46054305Iron deficiency alters the day-night variation in monoamine levels in mice
Q37393715Iron deficiency anemia in infancy exerts long-term effects on the tibialis anterior motor activity during sleep in childhood.
Q39150062Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome
Q89864796Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome
Q22251258Le syndrome des jambes sans repos
Q45201265Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging
Q33658871Mechanisms of iron metabolism in Caenorhabditis elegans
Q28566402Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons
Q36800596Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study
Q64088844Probable RBD Associates with the Development of RLS in Parkinson’s Disease: A Cross-Sectional Study
Q34754646Profile of altered brain iron acquisition in restless legs syndrome
Q48095045Relationship between hepcidin levels and periodic limb movement disorder in patients with obstructive sleep apnea syndrome
Q64863934Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Q48416860Restless legs syndrome in pediatric patients with chronic kidney disease
Q53228404Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.
Q37763512Restless legs syndrome: pathophysiology, clinical presentation and management
Q24626621Serum ferritin: Past, present and future

Search more.